20.01.2016 • NewsElaine BurridgeHydrogen Peroxidesmarket

AkzoNobel Acquires all of EkO Peroxide

AkzoNobel has boosted its position in the North American hydrogen peroxide market with the purchase of all outstanding shares in EkO Peroxide, a joint venture with OCI Peroxygens. Financial details of the transaction were not disclosed. The jv established nine years ago is headquartered at AkzoNobel’s site in Columbus, Mississippi, USA, where it operates a hydrogen peroxide plant with a capacity of 63,500 t/y.

Werner Fuhrmann, AkzoNobel’s executive committee member responsible for specialty chemicals, said the acquisition supports the company’s strategic growth objectives for bleaching chemicals, enabling it to strengthen its integrated platform for the production of hydrogen peroxide and sodium chlorate at the Columbus site. Fuhrmann added that the hydrogen peroxide market in North America has improved significantly in recent years.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.